Project Details
Description
Intrathecal Enzyme Replacement Therapy for Patients with Mucopolysaccharidosis Type I (Hurler Syndrome)
| Status | Finished |
|---|---|
| Effective start/end date | 7/9/07 → 6/30/18 |
Funding
- GENZYME CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.